6550--Molecular Oncology-MSI Testing

Form / Attachment / Pricing Sheet

This document outlines the "Salient Characteristics" for MSI Testing Reagent Cartridges, detailing the essential technical and functional requirements for the product. It serves as a specification for potential bidders to understand the performance and features expected.

• Automation: The assay must be fully automated with no reagent preparation required.
• Performance: Results should be available in approximately 150 minutes.
• Sample Handling: No sample extraction is needed prior to use, and testing can be performed on a minimum of one slice of FFPE tissue section.
• Quality Control: Elimination of the need for external quality control.
• Detection: Qualitative detection of mutations in 7 novel MSI loci (ACVR2A, BTBD7, DIDO1, MRE11, RYR3, SEC31A, and SULF2).
• Pricing Model: Reagent cartridge kits must be provided on a reagent rental basis, inclusive of:
  • Reagent cartridge kits
  • Idylla Instrument and Console
  • Annual preventative maintenance (PM) service

This attachment defines the critical technical specifications and service requirements for the MSI testing reagent cartridges. Bidders must ensure their proposed solution meets all listed salient characteristics. The pricing model requirement (reagent rental) is also a key factor for proposal development.

Solicitation / RFP / RFQ

This is a combined synopsis/solicitation (RFQ) for MSI Testing Reagent Cartridges CPK on a Reagent Rental basis for the Department of Veterans Affairs, VA Greater Los Angeles Healthcare System, Path and Lab Medicine Services. The acquisition is not set-aside for small businesses.

The solicitation requires the provision of MSI Assay (6 units/package), Idylla Console (ORR), and Idylla Instrument (ORR). Specific quantities and contract periods are outlined for multiple years.

• Contract Type: Firm-Fixed-Price

• Period of Performance: Base period from 05-22-2026 to 05-21-2027, with options for subsequent years up to 05-21-2031.

• Options: The contract includes options for increased quantity (52.217-6), option to extend services (52.217-8, limited to 6 months), and option to extend the term of the contract (52.217-9, total duration not to exceed five years).

• Questions Deadline: Wednesday, May 13, 2026, 1:00 PM Pacific Time, submitted in writing/email to Samuel.Han@va.gov.

• Quote Submission Deadline: Friday, May 15, 2026, 1:00 PM Pacific Time, submitted electronically via email to Samuel.Han@va.gov.

• Evaluation: Offers will be evaluated based on the lowest priced quotation that meets all salient characteristics in Attachment A and additional delivery requirements, and is both responsive and responsible. Acceptability of equipment/services will be verified against Attachment A.

• Required Documents: Vendor Quotation, completed Solicitation document (SF1449, Section B.1.1.a, B.1.4, B.2), and narratives demonstrating how offered products meet salient characteristics.

• This acquisition is unrestricted and not set-aside for small business concerns.

• The solicitation incorporates FAR clauses by reference, accessible at www.acquisition.gov.

• Specific clauses related to Buy American, Security Prohibitions, and Electronic Submission of Payment Requests are included.

• Attachment A details the Salient Characteristics for MSI Testing CPK.

Solicitation / RFP / RFQ

This is a combined synopsis/solicitation for commercial products or services, specifically a Request for Quotation (RFQ) for Molecular Oncology-MSI Testing Reagent Cartridges CPK on a Reagent Rental basis. This acquisition is for the Path and Lab department of the VA Greater Los Angeles Healthcare System.

• MSI Testing Reagent Cartridges CPK on a Reagent Rental basis.

• Salient Characteristics for MSI Testing CPK are detailed in Attachment A.

• Not specified in the provided text.

• Offers are being requested; a separate written solicitation will not be issued.

• Detailed solicitation instructions are provided in the ADDENDUM to FAR 52.212-1 INSTRUCTIONS TO OFFERORS- COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES.

• Response Date/Time/Zone: 05-15-2026 1:00PM PACIFIC TIME, LOS ANGELES, USA.

• This acquisition is NOT set-aside for small business concern.

• Solicitation Number: 36C26226Q0730.

• Product Service Code: 6550.

• NAICS Code: 325413.

• Contracting Office Address: Department of Veterans Affairs, Network Contracting Office 22, 4811 Airport Plaza Drive, Suite 600, Long Beach CA 90815.

• Place of Performance: VA Greater Los Angeles Healthcare System, Path and Lab Medicine Services (113), 11301 Wilshire Blvd, Los Angeles CA 90073, USA.

• Contact: Samuel Han, Contract Specialist, Samuel.Han@va.gov.

• This solicitation incorporates provisions and clauses by reference, accessible at www.acquisition.gov.

• Referenced documents: 36C26226Q0730 and Attachment A - Salient Characteristics - MSI Testing CPK.